Q3 2020

Filed Oct 23, 2020 · 10-Q · 23 days after period end · 0001091818-20-000228

Q3 2020 · 10-Q

Revenue—

Net Income

-$117.92K

N/M vs Q3 2019

EPS Diluted

-$0.01

— vs Q3 2019

Operating Cash Flowderived-$8,642N/M

Same quarter

Metric	Q3 2020	Q3 2019	Q3 2018	Q3 2017
Revenue	—	$5.96K	$5.51K	—
Net Income	-$117.92K	-$6.33K	-$6.64K	-$2.20K
EPS Diluted	-$0.01	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR